JO2571B1 - Universal controlled release composition - Google Patents

Universal controlled release composition

Info

Publication number
JO2571B1
JO2571B1 JO200665A JOP20060065A JO2571B1 JO 2571 B1 JO2571 B1 JO 2571B1 JO 200665 A JO200665 A JO 200665A JO P20060065 A JOP20060065 A JO P20060065A JO 2571 B1 JO2571 B1 JO 2571B1
Authority
JO
Jordan
Prior art keywords
controlled release
release composition
universal
universal controlled
matrix
Prior art date
Application number
JO200665A
Other languages
Arabic (ar)
Inventor
بدوان عدنان
الشيخ سالم معتز
الريماوي مياس
Original Assignee
الشركة الأردنية لأنتاج الأدوية
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by الشركة الأردنية لأنتاج الأدوية filed Critical الشركة الأردنية لأنتاج الأدوية
Priority to JO200665A priority Critical patent/JO2571B1/en
Application granted granted Critical
Publication of JO2571B1 publication Critical patent/JO2571B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a controlled-release pharmaceutical composition comprising at least one active agent and an inactive matrix, said matrix comprising chitosan and derivatives thereof, and further comprising a hydrophilic polysaccharide polymer selected from the group of carbohydrate gums, specifically xanthan gum, and to the preparation and use of said composition.
JO200665A 2006-03-09 2006-03-09 Universal controlled release composition JO2571B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO200665A JO2571B1 (en) 2006-03-09 2006-03-09 Universal controlled release composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO200665A JO2571B1 (en) 2006-03-09 2006-03-09 Universal controlled release composition

Publications (1)

Publication Number Publication Date
JO2571B1 true JO2571B1 (en) 2010-09-05

Family

ID=48045843

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200665A JO2571B1 (en) 2006-03-09 2006-03-09 Universal controlled release composition

Country Status (1)

Country Link
JO (1) JO2571B1 (en)

Similar Documents

Publication Publication Date Title
WO2007048219A3 (en) Sustained drug release composition
EP3895699A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
MY157790A (en) Trazodone composition for once a day administration
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
MX2009004439A (en) Ibuprofen composition.
NZ608239A (en) Aqueous drug delivery system comprising off - flavor masking agent
WO2009001099A3 (en) A pharmaceutical composition comprising polyaphron dispersion
MX2010005013A (en) Intranasal compositions.
WO2007100822A3 (en) Fluvastatin sodium pharmaceutical compositions
PL1994926T3 (en) Valsartan formulations
WO2006008173A3 (en) Pharmaceutical formulations for inhalation
GEP20125636B (en) Slow-release formulation based on glycogen and alginate association
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
WO2009074853A3 (en) Ophthalmic composition comprising phenylephrine
DE60319983D1 (en) Universal composition for controlled release of active ingredient containing chitosan
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
WO2010029093A3 (en) Compositions for percutaneous administration
WO2008138089A3 (en) Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer
WO2008055254A3 (en) Formulations and methods for oral delivery of proteins
JO2571B1 (en) Universal controlled release composition
BRPI0506630A (en) controlled release composition and method for administering a controlled release transmucosal aqueous drug
WO2008029351A3 (en) A modified release formulation comprising amoxicillin and clavulanate
BRPI0611526A2 (en) topical composition containing gelatin
WO2006111960A3 (en) Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent